Results 21 to 30 of about 4,863 (192)
European Journal of Case Reports in Internal Medicine, 2023 Background: Castleman disease (CD) is a rare lymphoproliferative disorder with various subtypes, including the HHV-8-negative/idiopathic multicentric CD (iMCD).
Helbies Bedier +3 more
doaj +1 more source
Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine
Vaccines, 2022 Idiopathic Multicentric Castleman Disease (iMCD) is a potentially life-threatening systemic disease whose complex symptomatology is due to cytokine dysregulation.
Christian Hoffmann +7 more
doaj +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
, 2020 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Nature Communications, 2022 Idiopathic multicentric Castleman disease (iMCD) is a life-threatening inflammatory disease requiring immediate intervention, for which the recommended first-line therapy is the Interleukin-6 pathway inhibitor siltuximab.
Sheila K. Pierson +11 more
doaj +1 more source
Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination
Journal of Cancer Research and Practice, 2023 Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder. The preferred primary treatment for iMCD is siltuximab, an anti-interleukin-6 antibody (anti–IL-6).
Chien-Yu Ker +3 more
doaj +1 more source
Potential Immunological Treatments in COVID-19 Patients
Düzce Tıp Fakültesi Dergisi, 2021 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seemed in Wuhan, China in December 2019. SARS-CoV-2 infection in human was named as coronavirus disease 2019 (COVID-19).
Muhammet Mesut Nezir Engin +1 more
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Idiopathic multicentric Castleman disease (iMCD) is challenging to diagnose due to clinical similarities with other conditions, such as Still's disease.
Magdalena Strach +3 more
doaj +1 more source
Immune-related adverse events of biological immunotherapies used in COVID-19
Frontiers in Pharmacology, 2022 The use of biological immunotherapeutic drugs is one of the options currently being evaluated and employed to manage COVID-19, specifically monoclonal antibodies, which have shown benefit by regulating the excessive immune response seen in patients with ...
Daniela Baracaldo-Santamaría +5 more
doaj +1 more source
Case Reports in Oncology, 2021 TAFRO syndrome is defined by the presence of thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis/renal dysfunction (R), and organomegaly (O) and can be seen with idiopathic multicentric Castleman disease (iMCD) or as an isolated process ...
Corinne Williams +5 more
doaj +1 more source
Diagnostics, 2022 Background: POEMS syndrome (POEMS) is a rare plasma cell clonal paraneoplastic syndrome consisting of polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes presenting with idiopathic multicentric Castleman disease (iMCD ...
Yong-Moon Lee +2 more
doaj +1 more source